Aptose Biosciences Inc. - Common Shares

CUSIP: 03835T200

Q3 2016 13F Holders as of 30 Sep 2016

Holder snapshot 6 signals
Share change
+395,665
SEC-reported price per share
$2.25
Indexed holders
10
Value change
+$885,330
Number of buys
6
Number of sells
4
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
2,556,332

Security key

03835T200

Report period

Q3 2016

Indexed institutions

10

Top holders

9

Ownership snapshot

Top reported holders of 03835T200 - Aptose Biosciences Inc. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FRANKLIN TEMPLETON INC
Disclosed value leader
FRANKLIN TEMPLETON INC
Comparable rows
0/10
Latest evidence
30 Jun 2016
13F Highest disclosed value: $3,508,000 10 rows are not safely comparable across share classes. Showing 1-6 of 10 holder rows.

Quick read

FRANKLIN TEMPLETON INC has the largest disclosed position value at $3.51M.

0 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FRANKLIN TEMPLETON INC's linked filing trail.
Disclosed position value Top 5
FRANKLIN TEMPLETON INC $3.51M
Cormorant Asset Management, LP $2.42M
BANK OF MONTREAL /CAN/ $128K
Callan Capital, LLC $29K
Knoll Capital Management, LLC $29K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 10 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FRANKLIN TEMPLETON INC
13F
Company
13F
—
denominator unverified
$3,508,000
1,416,666 shares
— 30 Jun 2016
Cormorant Asset Management, LP
13F
Company
13F
—
denominator unverified
$2,417,000
990,579 shares
— 30 Jun 2016
BANK OF MONTREAL /CAN/
13F
Company
13F
—
denominator unverified
$128,000
52,624 shares
— 30 Jun 2016
Callan Capital, LLC
13F
Company
13F
—
denominator unverified
$29,000
12,000 shares
— 30 Jun 2016
Knoll Capital Management, LLC
13F
Company
13F
—
denominator unverified
$29,000
11,933 shares
— 30 Jun 2016
ROYAL BANK OF CANADA
13F
Company
13F
—
denominator unverified
$27,000
11,159 shares
— 30 Jun 2016
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2016

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
10
Shares
2,899,922
Indexed holders
10
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2016 vs Q2 2016 Across Filers

Q2 2016 indexed holders
10
Q3 2016 indexed holders
10
Indexed holder difference
0
Investor Q2 2016 Shares Q3 2016 Shares Share Diff Share Chg % Q2 2016 value Q3 2016 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .